GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (STU:41L) » Definitions » Dividend-Payout-to-FFO

Laboratorios Farmaceuticos Rovi (STU:41L) Dividend-Payout-to-FFO


View and export this data going back to 2013. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Laboratorios Farmaceuticos Rovi Business Description

Traded in Other Exchanges
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.